AVOQ, LLC

Lobbying for OMEROS CORPORATION · Commercial-stage biopharmaceutical company

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · Washington · House · Senate · $20,000.00 income · posted Jun 11, 2025

Lobbying activity 1

Health Issues

General monitoring of health care issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem